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Double outlet right ventricle
Endocardial cushion
Septal defectsMembers of the GATA family of transcription factors are critical regulators of heart development and
mutations in 2 of them, GATA4 and GATA6 are associated with outﬂow tract and septal defects in human. The
heart expresses 3 GATA factors, GATA4, 5 and 6 in a partially overlapping pattern. Here, we report that
compound Gata4/Gata5 and Gata5/Gata6 mutants die embryonically or perinatally due to severe congenital
heart defects. Almost all Gata4+/−Gata5+/− mutant embryos have double outlet right ventricles (DORV),
large ventricular septal defects (VSD) as well as hypertrophied mitral and tricuspid valves. Only 25% of double
compound Gata4/Gata5 heterozygotes survive to adulthood and these mice have aortic stenosis. Compound
loss of a Gata5 and a Gata6 allele also leads to DORVs associated with subaortic VSDs. Expression of several
transcription factors important for endocardial and myocardial cell differentiation, such as Tbx20, Mef2c,
Hey1 and Hand2, was reduced in compound heterozygote embryos. These ﬁndings suggest the existence of
important genetic interactions between Gata5 and the 2 other cardiac GATA factors in endocardial cushion
formation and outﬂow tract morphogenesis. The data identify GATA5 as a potential genetic modiﬁer of
congenital heart disease and provide insight for elucidating the genetic basis of an important class of human
birth defects.stry, Microbiology and Immu-
Ottawa ON, Canada K1N 6N5.
r).
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Congenital heart disease (CHD) is estimated to occur at a prevalence
of 1–2% of live births and is the leading cause of death in the ﬁrst year of
life (Pierpont et al., 2007). Abnormal development of the outﬂow tract
(OFT) accounts for about 12–14% of all CHDs, leading to malformations
such as persistent truncus arteriosus (PTA), tetralogy of Fallot (TOF),
double outlet right ventricle (DORV) and transposition of the great
arteries (TGA) (Hoffman and Kaplan, 2002). Signiﬁcant efforts have
been deployed over the last decade to elucidate the cell and molecular
mechanisms involved in CHD. Several lines of evidence suggest that
CHD is heritable (Insley, 1987), but to date, only a few human genes
have been linked to CHDs. Many of those are developmental regulatory
genes. For example, mutations in NKX2.5 are associated with cases of
TOF and atrial septal defects (ASD) while mutations in the TBX5 gene
cause the Holt–Oram syndrome, an autosomal dominant disease with
varying cardiac defects (Basson et al., 1997; Goldmuntz et al., 2001; Li et
al., 1997; Schott et al., 1998). Moreover, mutations in GATA4 have been
associated with atrial and/or ventricular septal defects, TOF and PTA
(Garg et al., 2003; Nemer et al., 2006; Rajagopal et al., 2007).
Interestingly, heterozygous mutations of Gata4, Nkx2.5 and Tbx5 in
mice recapitulate the human phenotype (Biben et al., 2000; Bruneau etal., 2001; Rajagopal et al., 2007; Winston et al., 2010). Recently,
mutations in the humanGATA6 genehave been associatedwith PTA and
TOF (Kodo et al., 2009; S.C. Lin et al., 2010;Maitra et al., 2010).What has
emerged from combined human and mouse genetic studies is that
mutations in different genes can lead to similar cardiac defects while
mutations in the same gene can lead to varying defects. The complexity
of CHD is evident at both genetic and cellular levels, asmultiple lineages
contribute to proper heart development. Theﬁrst heartﬁeld contributes
to the formation of the left ventricle, the atrioventricular canal and both
atrial chambers (Buckingham et al., 2005). Whereas, the secondary
heart ﬁeld (SHF) contributes to the formation of the right ventricle
and the OFT (Kelly et al., 2001; Mjaatvedt et al., 2001; Waldo et al.,
2001). Remodeling of the OFT into the distinct vessels of the aorta
and pulmonary trunk requires complex interactions between the
myocardium, the endocardium and cardiac neural crest cells (NCC)
(Hutson and Kirby, 2007). Consequently, impaired development of the
OFT results in conotruncal defects.
Members of theGATA family of transcription factors play important
roles in differentiation, proliferation and survival of different cell
types. In the heart, 3 GATA factors are present in a partially overlapping
pattern (Molkentin, 2000; Nemer and Nemer, 2003; Patient and
McGhee, 2002). Gata4 is highly expressed in myocytes, endocardial
cells and epicardial cells of the heart. Embryos lacking Gata4 die by
E8.5 because of defects in ventral migration causing cardia biﬁda (Kuo
et al., 1997; Molkentin et al., 1997). Analysis of rescued Gata4−/−
embryos revealed cardiac defects including disrupted heart looping,
absence of endocardial cushion formation, lack of a proepicardial
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Several studieswere performed to further investigate the role of Gata4
in endocardial ormyocardial cell development. Inactivation ofGata4 in
endothelial cells causes embryonic lethality by E12.5 due to failure to
promote endocardial cushion formation and remodeling (Rivera-
Feliciano et al., 2006). Early myocardial speciﬁc deletion of Gata4
results in myocardial thinning and hypoplastic endocardial cushions
(Zeisberg et al., 2005). Moreover, haploinsufﬁciency of Gata4 has been
associated with cardiac defects including common atrioventricular
canal, DORV and hypoplastic ventricularmyocardium (Pu et al., 2004).
Gata6 is expressed in myocytes but also in neural crest as well as
endocardial and vascular smooth muscle cells (VSMC) (Nemer and
Nemer, 2003). Inactivation of Gata6 speciﬁcally in neural crest cells is
sufﬁcient to cause PTAs and lethality by E18.5-P2, revealing a role for
GATA6 in the patterning of the OFT and aortic arch (Lepore et al.,
2006). Loss of both Gata4 and Gata6 in mice leads to acardia,
suggesting that genetic interactions between these factors are
essential for the onset and/or maintenance of cardiogenesis (Zhao
et al., 2008). Interestingly, mice with compound heterozygous
mutation in Gata4 and Gata6 die embryonically around E13.5 due to
vascular defects; in addition, thesemice display PTA, evidence of failed
OFT septation as well as myocardial thinning. These results are
indicative of functional interactions between Gata4 and 6 in cardiac
and vascular development (Xin et al., 2006). In contrast to GATA4 and
6, GATA5 expression is more restricted to endocardial cells and
endocardial cushions of the OFT and atrioventricular canal during
heart development. The dynamic expression of GATA5 in endocardial
cells suggests a speciﬁc function for this transcription factor in
endocardial development. Consistent with this, faust (which encode
gata5) mutants in zebraﬁsh have cardia biﬁda and lack endocardial
cells (Reiter et al., 1999). In addition, downregulation of Gata5 in an
in vitro model of endocardial differentiation inhibits terminal
differentiation and expression of endocardial differentiation markers
(Nemer andNemer, 2002). An important role forGATA5 in endocardial
differentiation is further supported by recent ﬁndings showing that
lack of Gata5 in mice leads to bicuspid aortic valve formation (Laforest
et al., 2011). Thus, all three cardiac GATA factors appear to play
important functions in endocardial cushion development and/or
outﬂow tract morphogenesis.
Because expression of the three cardiac GATA factors partially
overlaps and since they can bind similar DNA regulatory elements and
activate common target promoters through heterotypic interactions
(Charronet al., 1999;Nemer andNemer, 2003),we testedwhetherGata5
might genetically interact with Gata4 and Gata6 in OFT development.
Here we show that Gata4+/−Gata5+/− and Gata5+/−Gata6+/− double
heterozygote mice die embryonically or perinatally due in large part to
profound defects of OFT development including DORVs and VSDs. The
results raise thepossibility that subtle alterations in the level or activity of
any 2 cardiacGATA factorsmight lead to human congenital heart defects.Materials and methods
Animals
Mice handling and experimentationwere performed in accordance
with institutional guidelines. All protocols were approved by the
institutional animal care committees.
Mice heterozygous for Gata4, Gata5 and Gata6 were generated and
genotypedaspreviouslydescribed (Aries et al., 2004;Koutsourakis et al.,
1999; Laforest et al., 2011). All lines were maintained in the C57/BL6
background. To generate double heterozygotes, mice heterozygous for
Gata4 or Gata6 were mated to Gata5 heterozygote mice and pregnant
mothers or newborn litters were sacriﬁced at various embryonic
timepoints and postnatal timepoints. The morning a vaginal plug was
observed was deﬁned as embryonic day (E) 0.5.Histology
Whole embryos were ﬁxed in 4% paraformaldehyde at 4 °C
overnight, dehydrated through graded ethanol series, embedded in
parafﬁn and sectioned at 4-μm intervals. Masson's trichrome staining
was carried out on heart sections using standard procedures to visualize
defects.
Cell count
Image J software was used to count the number of myocytes,
endocardial cells and cushions cells in three different sections of 3–4
different heart samples for each genotype. The different cell types are
easily distinguished morphologically in embryonic hearts.
Echocardiography
Transthoracic echocardiography was performed as described
before (Aries et al., 2004) using a VisualSonics Vevo 770 ultrasound
system with a RMV 707 30 MHz transducer. Doppler and M-mode
imaging was obtained from 70 days old mice. Groups of 3–6 mice
from different litters were used for the M-mode measurements and
Doppler readings at 70 days.
Quantitative polymerase chain reaction (Q-PCR)
Total RNA was isolated from whole hearts at E12.5 with TRIZOL
reagent (Invitrogen) according to the manufacturer's instruction.
cDNAs were generated from 2 μg of total RNA using the Omniscript RT
kit (Qiagen). Q-PCRwas performedwith cDNA diluted 1/100 using the
Qiagen Q-PCR kit. Brieﬂy, DNA template and 400 nM oligonucleotides
were used at an annealing temperature of 58 °C using the Quantitect
SYBR green PCR kit (QIAGEN) in an MX3500 real-time PCR machine
(Stratagene, La Jolla, CA). Mean gene expression was corrected by
GAPDH and calculated from wildtype and double heterozygote
embryos (n=3–6 per group). Primers used were as previously
reported (Laforest et al., 2011).
Statistical analysis
Values are presented as mean±S.E.M. and n refers to the number
of mice per group. For comparison of multiple groups, a one-way
ANOVA statistical test was performed. A Student's two-tailed t-test
was then performed to conﬁrm statistical signiﬁcance between two
groups. Statistical signiﬁcance was considered as Pb0.05.
Results
Reduced viability of Gata4+/−Gata5+/− embryos
Both Gata4 and Gata5 are expressed in the endocardial cushions at
the same embryonic stages (between E9 and E12). We investigated
possible in vivo interactions between them in heart development by
crossing mice heterozygous for either a Gata5 or a Gata4 allele.
According to Mendelian transmission, equal ratios of wildtypes, Gata4
heterozygotes, Gata5 heterozygotes and Gata4/Gata5 double heterozy-
gotes were expected. However, at weaning, Gata4+/−Gata5+/− double
heterozygotes (G4/G5 hets) were obtained at far lower frequency than
expected (6% vs 25%) (Fig. 1A). Analysis of embryos from timedmatings
suggested high perinatal lethality of G4/G5 hets, although decreased
viability was evident starting at E14.5 (Fig. 1A). Visual inspection of the
Gata4+/−Gata5+/− heterozygotes at E11.5 revealed no gross abnor-
malities but by E15.5, it was evident that the Gata4+/−Gata5+/−
heterozygoteswere smaller (Figs. 1B–K). Todetermine if this phenotype
was caused by growth retardation, the number of somites was
calculated at E10.5; no signiﬁcant changes were observed among all
Fig. 1. Reduced viability of Gata4+/−Gata5+/− heterozygotes. (A) Frequency of genotypes obtained from intercrossing Gata4+/− and Gata5+/− mice. Note the reduced viability of
compound Gata4+/−Gata5+/− heterozygotes at weaning and the reduced frequency of genotypes (by 25%) in Gata4+/−Gata5+/− starting at E14.5; another 50% is lost perinatally.
(B–K) Representative images of E11.5 (E, F) and E15.5 (J, K) in Gata4+/−Gata5+/− heterozygotes as compared to their littermates. Note the reduced size of double het embryos at
E15.5. Embryonic lethality of 30% of Gata4+/−Gata5+/− is noted as shown in a representative embryo (K). Bars=1000 μm (B–F) and 2000 μm (G–K).
370 B. Laforest, M. Nemer / Developmental Biology 358 (2011) 368–378genotypes, indicating that the Gata4+/−Gata5+/− heterozygotes were
not developmentally retarded. Crown–rump measurement of the
embryo size at E15.5 however revealed that the Gata4+/−Gata5+/−
heterozygotes are signiﬁcantly smaller than all their other littermates
(WT, 186.77 mm±3.90; Gata4+/−, 183.90 mm±3.15; Gata5+/−,
180.60 mm±2.85 and Gata4+/−Gata5+/−, 166.18 mm±2.71,
Pb0.005). Moreover, 30% of Gata4+/−Gata5+/− embryos were dead at
E15.5 (Fig. 1K).
Gata4+/−Gata5+/− double heterozygotes display DORVs and VSDs
In order to determine the cause of lethality, histological analyses
were performed on E15.5 Gata4+/−Gata5+/− double heterozygotes.
They revealed profound structural cardiac defects. A double outlet
right ventricle (i.e. the aortic valve opens in the right ventricle instead
of the left ventricle) as well as large ventricular septal defects was
evident in 86% of embryos (Figs. 2C, D, G and H). This was not
observed in Gata5+/− heterozygote littermates and only 29% of
Gata4+/− had a DORV (Table 1). Moreover, some Gata4+/−Gata5+/−
embryos (2/7 embryos) had a complete atrioventricular canal defect,
meaning a single atrioventricular valve associated with atrial and
ventricular septal defects (Fig. 2L and Table 1). Gata5+/− heterozygote
littermates did not demonstrate this defect and had two separate
atrioventricular valves while 1/7 Gata4+/− embryo (only 14%) had a
common atrioventricular valve (Figs. 2I–J). As both GATA4 and GATA5
are expressed in the atrioventricular (AV) cushion, we wereinterested to know if the valve morphology was normal. We found
that the tricuspid and mitral valves of Gata4+/−Gata5+/− double
heterozygotes were hypertrophied compared to Gata4+/− and
Gata5+/− littermates, a situation that could cause stenosis (Fig. 2K
and Table 1). As these defects are all thought to arise from abnormal
development of endocardial cushions, the results suggest that Gata4
and Gata5 genetically interact for proper EC development.
Gata4 and Gata5 cooperate in endocardial cushion formation
Histological analysis of tissue sections at E11.5 revealed smaller
hypotrabeculated hearts in Gata4+/−Gata5+/− compared to single het-
erozygous orwildtype littermates (Figs. 3A–D). Highermagniﬁcation of
the left ventricle also revealed a reduction in the left ventricular wall
(Figs. 3E–H). Cell counting indicated signiﬁcantdecreases in thenumber
of myocytes and endocardial cells in the left ventricle of G4/G5 hets at
E11.5 compared to Gata5+/− but not to Gata4+/− littermates (Fig. 3Q).
By E15.5, 71% (5/7)Gata4+/−Gata5+/− embryos had thinning of the left
and right ventricular compact zone (WT, 15.33 mm±0.78; Gata5+/−,
15.91 mm±0.13; Gata4+/−, 10.44 mm±0.52 and Gata4+/−Gata5+/−,
8.70 mm±1.44) (Figs. 3I–L). Of note, similar ventricular hypoplasiawas
observed in the Gata4+/− embryos at E11.5 and E15.5, suggesting that
absence of a Gata5 allele does not appear to worsen the myocardial
defects of Gata4 haploinsufﬁcient hearts (Figs. 3F and J).
At E15.5 Gata4+/−Gata5+/− embryos show AV canal defects, VSDs
and hypertrophied AV valves. These structures arise from endocardial
Fig. 2. Cardiac defects inGata4+/−Gata5+/− heterozygotes. Trichrome staining of transverse sections of E15.5 embryos. Note how in single hets (A and B), the aortic valve opens in the left
ventricle whereas in Gata4+/−Gata5+/− embryos, the aortic valve opens in the right ventricle (C and D), a phenotype known as double outlet right ventricle (DORV). (E–H) Transverse
section through theheart showing an intact ventricular septum inGata4+/− andGata5+/− embryos and amembranous ventricular septal defect (VSD) inGata4+/−Gata5+/− embryos (star
inG andH). (I–L) Transverse section through the heart showing normalmitral and tricuspid valves in the single hets, whereas themajority ofGata4+/−Gata5+/− embryos havemitral and
tricuspid stenosis (K) and a minority have a common atrioventricular valve (L). Bars=300 μm. AV, aortic valve; LV, left ventricle; RV, right ventricle.
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E12.5. Consistent with a role for both factors therein, endocardial
cushions of Gata4/Gata5 compound heterozygote embryos were
smaller but properly formed (Figs. 3M–P). Gata4+/−Gata5+/−mutant
embryos showed a larger reduction in the total number of cushion
cells within the atrioventricular endocardial cushion compared to
Gata4+/−, Gata5+/− and wildtype littermates. These results indicate
that GATA4 and GATA5 cooperate in endocardial cushion formation in
the AV canal.
Q-PCR analysis on RNA isolated from hearts of WT and Gata4/
Gata5 compound mutants at E12.5 revealed that Gata4 and Gata5
transcripts were reduced by 50% and 60% compared toWT littermates
with no change in Gata6 levels (Figs. 4A–C). Interestingly, we noticed
an upregulation of Nppb transcripts only in double hets, possibly
indicative of early cardiac stress. Consistent with this, the level of
several cardiac genes was speciﬁcally altered in the double hets as
comparedwith control or single het littermates (Fig. 4G).Mef2c, Tbx20
and Bmp7 transcripts were signiﬁcantly decreased only in G4/G5mice
(Figs. 4D, F and I). Moreover, we observed more pronounced
decreases in mRNA levels of components of the Notch pathway in
double hets relative to Gata4+/−, which already displayed changes
compared to wildtype and Gata5+/− littermates. They include the
Notch ligand Jag1, Notch1 and the Notch target Hey1 (Figs. 4J–L). No
signiﬁcant alteration in the level of other genes implicated inTable 1
Summary of the cardiac phenotypes of the Gata4/Gata5 double heterozygotes at E15.5.
MV, mitral valve; TV, tricuspid valve, VSD, ventricular septal defect.
Phenotype WT Gata4+/− Gata5+/− Gata5+/−Gata4+/−
Normal 5/5 3/7 5/5 1/7
Double outlet right ventricle 0/5 2/7 0/5 6/7
Small VSD 0/5 3/7 0/6 1/7
Large membranous VSD 0/5 2/7 0/5 5/7
Atrioventricular septal defect 0/5 1/7 0/5 2/7
Thick MV and TV 0/5 2/7 0/5 4/7
Myocardial thinning 0/5 4/7 0/5 5/7endocardial cushion formation like Tgfβ1, Tgfβ2, Bmp2, Bmp4, erbb3
and Hey2 was evident (data not shown).
Adult Gata4/Gata5 compound mutants have aortic stenosis
Only 25% of Gata4+/−Gata5+/− double heterozygotes survive to
adulthood; we were interested in assessing cardiac structure and
function in this subgroup. Data obtained from echocardiographic
measurements on 70 days oldmice, revealed increased left ventricular
mass and signiﬁcantly decreased ejection fraction in adult G4/G5 hets
compared to wildtype, Gata4+/− and Gata5+/− littermates (Fig. 5A
and data not shown). Hemodynamic evaluation revealed increased
mean pressure gradient through the aortic valve ofGata4+/−Gata5+/−
double heterozygotes (Fig. 5B). As shown on the graph, nearly half of
the G4/G5 hets (3/7) had a very high pressure gradient compared to
wildtype, Gata4+/− and Gata5+/− littermates. These observations
suggested the presence of aortic valve constriction. Histological
analysis of these hearts conﬁrmed the presence of left ventricular
hypertrophy compared to wildtype and Gata4+/− and Gata5+/−
littermates and revealedmassively hypertrophied aortic valve in adult
Gata4+/−Gata5+/− double heterozygotes (Fig. 5G). Together, the
results are consistent with defective valve development leading to
aortic stenosis.
Disrupted valvulogenesis in Gata5+/−Gata6+/− embryos
The Gata5 protein also overlaps with Gata6 in outﬂow tract
cushions. To determine if Gata6 and Gata5 genetically interact, we
generated Gata5+/−Gata6+/− mice. Only 1% of the expected
Gata5+/−Gata6+/− double heterozygotes (G5/G6 hets) were present
at weaning (postnatal day 30), suggesting that the combined
mutations result in embryonic or perinatal lethality (Fig. 6A). Analysis
of 13 post-natal litters revealed that 47% (10/21 embryos) of mice
heterozygous for both Gata5 and Gata6 were dead at birth.
Postmortem analysis of these Gata5+/−Gata6+/− hearts revealed a
100% penetrance for DORV, associated with massive dilatation of the
right atrium. Analysis of E15.5 and E18.5 embryos indicated reduced
Fig. 3. Ventricular wall and endocardial cushion defects in Gata4+/−Gata5+/− embryos. Trichrome staining of transverse sections of wildtype, Gata4+/−, Gata5+/− and
Gata4+/−Gata5+/−E11.5 embryos. (A–D)Noteventricularwall thinning andhypotrabeculation indoublehets aswell as inGata4het. Bars=200 μm. (E–H)Highermagniﬁcationof the left
ventricularwall. Bars=75 μm. (I–L) Trichrome staining of the left ventricularwall ofwildtype,Gata4+/−,Gata5+/− andGata4+/−Gata5+/− E15.5 embryos. Note the reduced compact zone
thickness in the double hets as well as in Gata4 hets. Bars=300 μm. (M–P) Transverse section through the AV endocardial cushions of WT, Gata4+/−, Gata5+/− and Gata4+/−Gata5+/−
embryos at E11.5. Endocardial cushions of Gata4+/−Gata5+/− embryos are properly formed although a bit smaller. Bars=100 μm. (Q) Quantiﬁcation of the number of cells in the left
ventricle or AV canal (* Pb0.05, ** Pb0.001, *** Pb0.0001). Statistical signiﬁcance is compared to WT controls. AVC, atrioventricular canal; LV, left ventricle.
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at any of the stages and crown–rump measurement of the embryos
(WT, 183.64 mm±7.75; Gata5+/−, 186.02 mm±5.42; Gata6+/−,
186.24 mm±2.21; Gata5+/−Gata6+/−, 182.86 mm±2.10) at E15.5
were not signiﬁcantly different.
To determine the etiology of the embryonic and perinatal lethality
of Gata5+/−Gata6+/− embryos, we sectioned embryos at E15.5, when
both ventricles are completely septated and the four valves of the
heart have formed. Histological analysis at this stage demonstrated
the presence of a DORV in 86% of Gata5+/−Gata6+/− embryos
(Fig. 7D). Similar to the Gata4/Gata5 compound embryos, we also
found the presence of VSDs but only at the level of the aortic valve
(Fig. 7H). The VSD was present over 30–50 μm, which was much
smaller than the ones in the Gata4/Gata5 double heterozygotes
(125–200 μm). We also noticed that a subset of Gata5+/−Gata6+/−
embryos had increased thickness of the left ventricular compact zonecompared to WT, Gata5+/− and Gata6+/− littermates (data not
shown). The AV and semilunar valves were formed properly and did
not show signs of hypertrophy. No other cardiac defects were noted. A
summary of the phenotypes is given in Table 2.
Gene expression studies were performed on RNA isolated from
hearts of wildtype, Gata5+/−, Gata6+/− and Gata5+/−Gata6+/−
mutants at E12.5. Expression of Gata5 and Gata6 transcripts was
reduced by 40–50% in compound mutants while the expression of
Gata4 was not signiﬁcantly altered (Figs. 8 A–C). In contrast to what
was observed in the G4/G5 hets, Mef2c transcripts were unchanged
and Nppb mRNA was downregulated in G5/G6 hets (Figs. 8D and G).
Tbx20mRNA levels weremoremodestly but signiﬁcantly decreased in
these embryos (Fig. 8F). A 2-fold increase in Raldh2mRNA levels was
noted only in the double hets, which could potentially explain the
presence of DORV as excess retinoic acid signaling leads to
conotruncal malformations such as TGA, DORV and TOF (Nakajima
Fig. 4.Modulation of gene expression in Gata4+/−Gata5+/− embryos. (A–L) Q-PCR analysis performed on whole hearts of E12.5 embryos. Transcript levels are normalized to GAPDH
in each sample. Note the downregulation of Mef2c, Nkx2.5, Tbx20, Bmp7, Jag1, Notch1 and Hey1 transcripts and the upregulation of Nppb transcripts in Gata4+/−Gata5+/− embryos
compared to wildtype littermates (*, 3, # Pb0.05; n=3–6 per genotype. * Statistical signiﬁcance vs Gata4+/−; 3 statistical signiﬁcance vs Gata5+/−; and # statistical signiﬁcance
vs WT).
373B. Laforest, M. Nemer / Developmental Biology 358 (2011) 368–378et al., 1996). A signiﬁcant 30% decrease of Hand2 transcripts was also
observed in Gata5/Gata6 compound embryos (Fig. 8H). Together, the
data reveal important genetic interactions between Gata5 and Gata6
in outﬂow tract development and identify potential new GATA target
genes therein.
Discussion
Transcription factors Gata4, Gata5 and Gata6 are present at various
stages of heart development and are important cardiac regulators
(Nemer and Nemer, 2010).Within the heart, their expression pattern is
unique but two or more GATA factors are often co-expressed in distinct
cell types or at speciﬁc developmental stages. Most notably, expression
of Gata5 overlapswith that of Gata4 in endocardial cells andwith that of
Gata6 in cushion cells of the outﬂow tract; all 3 factors are present in the
secondary heart ﬁeld. In the present study, we show that compoundhaploinsufﬁciency of Gata5 and either Gata4 or Gata6 results in
embryonic and perinatal lethality due to defective heart formation.
The cardiac phenotype of Gata4+/−Gata5+/− heterozygotes include
DORV, very large VSDs, complete AV canal defects and mitral and
tricuspid stenosis. The Gata4/Gata5 compound heterozygotes who
survive to adulthood show signs of aortic stenosis. Similarly, compound
haploinsufﬁciency of Gata5 and Gata6 leads to cardiac anomalies that
include DORVs and VSDs. The defects observed in the double
heterozygote embryos are either distinct or more pronounced than
those found in their single heterozygote parents or littermates,
indicative of a cooperative function for GATA factors during cardiac
morphogenesis. The phenotype of the Gata4+/−Gata5+/− heterozy-
gotes reported here differs from the one recently published by Singh K
et al. (Singh et al., 2010). In their study, Singh K et al. showed that
Gata4+/−Gata5+/− embryos hadmyocardial thinningbyE14.5 butwere
viable; however Gata4+/−Gata5−/− embryos had a more severe
Fig. 5. Aortic stenosis in adult Gata4+/−Gata5+/− heterozygotes. (A) Echocardiography of wildtype, Gata4+/−, Gata5+/− andGata4+/−Gata5+/−mice at 70 days (* Pb0.5, n=3–6 per
group). Note the increase in LV mass over bodyweight for Gata4+/−Gata5+/−mice, suggesting left ventricular hypertrophy. (B) Echocardiography of wild-type, Gata4+/−, Gata5+/− and
Gata4+/−Gata5+/−mice at 70 showing increased pressure gradients through the aortic valve (AV) (n=5 for WT, Gata4+/− and Gata5+/− littermates). Three out of seven Gata4/Gata5
compound heterozygotes have very high mean pressure gradient through the aortic valve. (C–F) Trichrome staining of a frontal section from 90 days old mice. Note the increased
ventricular hypertrophy of Gata4/Gata5 compound heterozygotes. Bar=1000 μm. LA, left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle. (G–J) Trichrome staining of a
frontal section of the aortic valve in these samemice. Note the hypertrophied aortic valve inGata4+/−Gata5+/− heterozygotes compared towildtype, Gata4+/− and Gata5+/− littermates.
Bar=300 μm.
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similar to our G4/G5 hets. This indicates increased severity of the
phenotype in our crosses, consistent with the heightened phenotype of
our Gata5 null mice as compared to theirs (Laforest et al., 2011). Given
this and the contribution of the genetic background to cardiac defects in
Gata4+/−mice (Pu et al., 2004), we hypothesize that differences in the
genetic background of our lines as compared to those of Singh et al.
underlie the differences in cardiac phenotype expressivity. Previously,
haploinsufﬁciency of both Gata4 and Gata6 revealed an important role
for these 2 GATA factors in cardiomyocyte proliferation and OFT
septation (Xin et al., 2006; Zhao et al., 2008).Whilewe had no evidence
for genetic interaction between Gata5 and either of the other 2 cardiac
GATA proteins in myocardial proliferation there was clear evidence of
genetic interaction in cushion formation and OFT remodeling. Together
with these studies, our present work underscores the exquisite
sensitivity of the OFT to GATA protein dosage and reveals the
importance of cooperative interactions between any 2 cardiac GATA
factors in regulating various events of cardiovascular development.Cooperative roles of GATA4, 5 and 6 in cardiac development
The majority of Gata4/Gata5 and Gata5/Gata6 double heterozygote
embryos developed DORVs, which is thought to occur from abnormal
rotation of the OFT. Results of previous work have suggested that the
myocardium of the OFT and the right ventricle are derived from a
population of cells located within the secondary heart ﬁeld (Kelly et al.,
2001; Mjaatvedt et al., 2001; Waldo et al., 2001). According to Bajolle F
et al., the myocardium at the base of the OFT is required for normal
positioning of the great vessels (Bajolle et al., 2008). GermlineGata4 and
Gata6 mutant mice die too early embryonically to be able to evaluate
their function in OFT morphogenesis (Koutsourakis et al., 1999; Kuo
et al., 1997; Molkentin et al., 1997). Gata4 hypomorphs have DORVs,
clearly indicating that Gata4 is required in OFT rotation (Crispino et al.,
2001; Pu et al., 2004). However, this phenotypewasnot producedwhen
Gata4wasdisrupted in the SHF leading the authors to suggest thatGata5
and Gata6might compensate for Gata4 in the SHF as theywere robustly
expressed in the pharyngeal mesoderm (Rojas et al., 2008). Deletion of
Fig. 6. Reduced viability of Gata5+/−Gata6+/− heterozygotes. (A) Frequency of genotypes obtained from intercrossing Gata5+/− and Gata6+/− mice. Embryonic and perinatal
lethality of Gata5+/−Gata6+/− heterozygotes is demonstrated by the reduced frequencies of Gata5+/−Gata6+/− embryos at various developmental stages. (B–J) Dissection and
visual inspection of Gata5+/−Gata6+/− heterozygotes. Bars=1000 μm (B–E), 2000 μm (F–J).
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results in the formation of PTAs and DORVs andGata4/Gata6 compound
heterozygosity leads to the formation of a single OFT vessel (Lepore
et al., 2006). These observations, coupled with our results, clearly
indicate that OFT defects seem to be a common consequence of loss of
twoGATAalleles, suggesting that a threshold of GATA factors is essential
in the rotation and patterning of the OFT. Whether or not this reﬂects
action ofGATA factors in the samecell type (SHFor endocardial derived)
or complementation of a defective pathway arising from 2 distinct
lineages remain to be deﬁned.
Endocardial cushion defects of Gata4+/−Gata5+/− embryos
Our work demonstrates that concomitant loss of one allele of
Gata4 with one allele of Gata5 leads to VSDs, AV canal defects and AV
valve hypertrophy with variable penetrance. These anomalies arethought to arise from abnormal endocardial cushion formation and
are consistent with the presence and role of Gata4 and Gata5 in
endocardial cell expansion and differentiation (Nemer and Nemer,
2002; Rivera-Feliciano et al., 2006). The process of endocardial
cushion formation starts at E9.5 in the mouse and requires complex
interactions between the endocardium and myocardium. In response
to diverse signals, endocardial cells go through an epithelial-to-
mesenchymal transformation (EMT) and migrate into the cushion
jelly; later in development these cushions will fuse together and will
be remodeled to form the valves of the hearts (Person et al., 2005). In
the compound Gata4/Gata5 heterozygotes, AV cushion formation
appears relatively normal at E11.5. However, we noticed reduced
number of cushion cells within the endocardial cushion, similar to the
decreased number of mesenchymal cells in the AV cushion of Gata5
null mice, suggestive of a role for both Gata4 and Gata5 in cushion
formation (Laforest et al., 2011). Whether these interactions involve
Fig. 7. Cardiac defects of Gata5+/−Gata6+/− heterozygotes. Trichrome staining of transverse sections of E15.5 wildtype (A, E), Gata5+/− (B, F), Gata6+/− (C, G) and Gata5+/−Gata6+/−
(D, H) embryos. Inwildtype,Gata5+/− andGata6+/− embryos (A–C), the aortic valve opens in the left ventricle. InGata5+/−Gata6+/− embryos, the aortic valve opens in the right ventricle
(D), leading to double outlet right ventricle (DORV). (E–H) Transverse section through the heart showing an intact ventricular septum in wildtype, Gata5+/− and Gata6+/− embryos. In
Gata5+/−Gata6+/− embryos (H), a membranous ventricular septal defect (VSD) is observed, which is associated with the DORV (arrow). Bars=300 μm (A–D) and 100 μm (E–H). AV,
aortic valve; LV, left ventricle; RV, right ventricle.
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in the endocardium where both factors are expressed will need to be
clariﬁed. Generation of Gata4/Gata5 double heterozygotes in which
Gata4 and Gata5 are deleted only in endocardial cells will help address
this question.
GATA downstream targets
The cardiac GATA factors have been shown to regulate a large
number of cardiac genes including Nppa, Nppb, Mef2c, Nkx2.5, Bmp4,
Myh6 andMyh7 (Charron et al., 1999; Dodou et al., 2004; Grepin et al.,
1994;Nemer andNemer, 2003).Moreover, Gata4 andGata6 are able to
heterodimerize and synergistically activate several of these promoters
(Charron et al., 1999).While the phenotype ofG4/G5 andG5/G6double
hets was very similar, distinct changes in gene expression were noted
suggesting that genetic interactions between Gata5 and the other 2
Gata factors disrupt some common but also different developmental
pathways. For example, haploinsufﬁciency of Gata5 combined with
loss of either a Gata4 or Gata6 allele resulted in reduced expression of
Nkx2.5, Tbx20 and Hand2 but Mef2c levels were changed only in
Gata4/Gata5 double hets. Loss of Hand2 results in embryonic lethality
and absence of right ventricle formation (Srivastava et al., 1997).
Hand2 is expressed in myocardial, endocardial and neural crest
lineages. Interestingly, deletion of Hand2 from neural crest cells is
sufﬁcient to produce an identical phenotype as the one reported here
(i.e.DORVs and VSDs) possibly through regulation of proliferation and
differentiation of SHF derived cells (Holler et al., 2010; Morikawa and
Cserjesi, 2008). Moreover, Hand2 transcriptionwas shown to be GATA
dependent (McFadden et al., 2000). Similarly, loss of Tbx20 revealed a
critical role in OFT development (Takeuchi et al., 2005). Tbx20 is
expressed in both myocardial and endocardial cells where it is
required for proliferation and differentiation (Shelton and Yutzey,
2008). A role for GATA factors in regulating Tbx20 has not yet been
reported in the mammalian heart but in Drosophila, the Tbx20Table 2
Summary of the cardiac phenotypes of the Gata5/Gata6 double heterozygotes at E15.5.
VSD, ventricular septal defect.
Phenotype WT Gata5+/− Gata6+/− Gata5+/−Gata6+/−
Normal 5/5 5/5 5/5 1/7
Double outlet right ventricle 0/5 0/5 0/5 6/7
Membranous VSD 0/5 0/5 0/5 6/7
Thick myocardium 0/5 0/5 0/5 5/7ortholog, neuromancer was shown to be a downstream mediator of
the GATA factor pannier in the heart (Qian and Bodmer, 2009). On the
other hand,Nkx2.5 transcription is GATAdependent and loss ofNkx2.5
causes septal, valvular andmyocardial dysmorphogenesis (Biben et al.,
2000; Grepin et al., 1997; Lien et al., 1999). Our data reveal exquisite
sensitivity of Nkx2.5 to Gata4 and Gata6 levels but not to Gata5
possibly reﬂecting changes in myocytes where Gata5 is not detectably
expressed. Lastly, it is noteworthy that Raldh2 is upregulated only in
G5/G6 hets. Excess retinoic acid signaling speciﬁcally inhibit OFT
cushion remodelingwhile Raldh2nullmice have cardiac abnormalities
due to defective SHF cell differentiation (X. Lin et al., 2010;Nakajima et
al., 1996). Dysregulation of Rald2 speciﬁcally in G5/G6 hets may
account for several of the cardiac phenotypes observed in the double
G5/G6 embryos. Interestingly, G4/G5 double hets but notG5/G6 double
hets showeddecreased expressionof Bmp7 and several components of
theNotchpathway,which is critical for proper cushionmorphogenesis
especially for outﬂow tract septation and valve formation (High et al.,
2009; Luna-Zurita et al., 2010; Rutenberg et al., 2006; Timmerman et
al., 2004). Future studies will need to determine whether this
speciﬁcity reﬂects differential regulation of downstreamGATA targets
or cell speciﬁc interactions between Gata5 and the other 2 GATA
proteins (in early endocardial cells Gata4 but not Gata6 is prominently
expressed).
GATA4, GATA5 and GATA6 in human CHD
Heterozygous mutations in GATA4 and GATA6 have been linked to
congenital heart defects in humans (Garg et al., 2003; Kodo et al.,
2009; Nemer et al., 2006; Pehlivan et al., 1999; Zhang et al., 2008). The
CHDs associated with mutations in GATA4 are predominantly ASDs,
VSDs but DORV, TOF and pulmonary stenosis have also been reported.
Recently, mutations in GATA6 in humans have been associated with
PTA. To date, no GATA5mutations have been reported in human CHD.
Despite the signiﬁcant efforts of the past decade to elucidate the
molecular mechanisms and the genetic basis of congenital heart
defects, the fundamental causes for the majority of CHD remain
unidentiﬁed. CHD has an increased risk of recurrence within families;
among affected relatives, the cardiac phenotypes are usually different
and occur with variable penetrance and expressivity, likely indicating
that modifying factors including genetic and environmental inﬂuence
the phenotype (Gill et al., 2003). Consistentwith this, inﬂuences of the
genetic background on the phenotype are now well documented in
experimental animal models and in humans (Bruneau et al., 2001;






































































































































Fig. 8.Modulation of gene expression in Gata5+/−Gata6+/− embryos. (A–I) Q-PCR analysis performed on hearts of E12.5 embryos. Transcript levels are normalized to GAPDH in each
sample. Expression of Gata5 and Gata6 is reduced by 40–50% and there are no signiﬁcant changes in the levels of Gata4mRNA. Note the downregulation of Nppb, Nkx2.5, Hand2 and
Tbx20 transcripts and the increased expression of Raldh2mRNA (*, 3, # Pb0.05, n=3–6 per genotype. * Statistical signiﬁcance vs Gata5+/−; 3 statistical signiﬁcance vs Gata6+/−; and
# statistical signiﬁcance vs WT).
377B. Laforest, M. Nemer / Developmental Biology 358 (2011) 368–378study suggest that GATA5 may be an important genetic modiﬁer that
could potentially contribute to human CHD and more speciﬁcally to
defects of the OFT.Acknowledgments
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